Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Arnica Balsam is a topical herbal medicinal product containing extracts from the flowers of *Arnica montana*. Developed and marketed by medphano Arzneimittel, it is indicated for the external treatment of blunt injuries, including bruises, sprains, contusions, and localized muscle pain. The therapeutic efficacy of arnica is attributed to its sesquiterpene lactone constituents, such as helenalin, which exert anti-inflammatory effects by inhibiting the activation of the transcription factor NF-κB. This inhibition reduces the expression of pro-inflammatory genes, thereby alleviating swelling and pain associated with tissue trauma.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on arnica balsam.